Cepheid Logo
Request Info
Sijainti / kieli

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

{{initials}}
Main Menu
Sijainti / kieli

{{headingText}}

{{paragraphText}}

{{continueBtnLabel}}

Request Info

Request Info
  • WHO EUL

Xpert® Hemorrhagic Fever Panel

img-xpert-hemorrhagic-fever-panel-hero

When Clarity Matters Most.

Rapid Answers. Confident Action. No Compromise.

WHO EUL only. May not be available in all countries.

The Need 

Rapidly identify patients with suspected viral hemorrhagic fever

  • Ebola virus disease outbreaks continue to pose a significant global health threat requiring rapid identification and public health response.1,2
  • Lassa fever is estimated to cause 100,000–300,000 infections and approximately 5,000 deaths annually in West Africa.3,4
  • Marburg virus and Crimean-Congo hemorrhagic fever (CCHF) continue to cause outbreaks across multiple regions, with CCHF responsible for an estimated 10,000-15,000 human infections annually, highlighting the need for rapid detection and outbreak response.6-8
     

Support timely infection control and outbreak response

  • Early symptoms of Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever (CCHF) are often non-specific and difficult to distinguish from other febrile illnesses.1
  • Rapid detection is critical to support patient isolation, infection prevention measures, and public health notification.1,2

Connect To Better Outcomes

Request Info

Insights

Get More Insights